Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuroscience Antibodies and Assays Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Consumables
1.2.3 Instruments
1.3 Market by Application
1.3.1 Global Neuroscience Antibodies and Assays Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Academic & Research Institutes
1.3.4 Hospitals & Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neuroscience Antibodies and Assays Market Perspective (2018-2033)
2.2 Neuroscience Antibodies and Assays Growth Trends by Region
2.2.1 Global Neuroscience Antibodies and Assays Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Neuroscience Antibodies and Assays Historic Market Size by Region (2018-2023)
2.2.3 Neuroscience Antibodies and Assays Forecasted Market Size by Region (2024-2033)
2.3 Neuroscience Antibodies and Assays Market Dynamics
2.3.1 Neuroscience Antibodies and Assays Industry Trends
2.3.2 Neuroscience Antibodies and Assays Market Drivers
2.3.3 Neuroscience Antibodies and Assays Market Challenges
2.3.4 Neuroscience Antibodies and Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neuroscience Antibodies and Assays Players by Revenue
3.1.1 Global Top Neuroscience Antibodies and Assays Players by Revenue (2018-2023)
3.1.2 Global Neuroscience Antibodies and Assays Revenue Market Share by Players (2018-2023)
3.2 Global Neuroscience Antibodies and Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neuroscience Antibodies and Assays Revenue
3.4 Global Neuroscience Antibodies and Assays Market Concentration Ratio
3.4.1 Global Neuroscience Antibodies and Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuroscience Antibodies and Assays Revenue in 2022
3.5 Neuroscience Antibodies and Assays Key Players Head office and Area Served
3.6 Key Players Neuroscience Antibodies and Assays Product Solution and Service
3.7 Date of Enter into Neuroscience Antibodies and Assays Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neuroscience Antibodies and Assays Breakdown Data by Type
4.1 Global Neuroscience Antibodies and Assays Historic Market Size by Type (2018-2023)
4.2 Global Neuroscience Antibodies and Assays Forecasted Market Size by Type (2024-2033)
5 Neuroscience Antibodies and Assays Breakdown Data by Application
5.1 Global Neuroscience Antibodies and Assays Historic Market Size by Application (2018-2023)
5.2 Global Neuroscience Antibodies and Assays Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Neuroscience Antibodies and Assays Market Size (2018-2033)
6.2 North America Neuroscience Antibodies and Assays Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Neuroscience Antibodies and Assays Market Size by Country (2018-2023)
6.4 North America Neuroscience Antibodies and Assays Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neuroscience Antibodies and Assays Market Size (2018-2033)
7.2 Europe Neuroscience Antibodies and Assays Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Neuroscience Antibodies and Assays Market Size by Country (2018-2023)
7.4 Europe Neuroscience Antibodies and Assays Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neuroscience Antibodies and Assays Market Size (2018-2033)
8.2 Asia-Pacific Neuroscience Antibodies and Assays Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Neuroscience Antibodies and Assays Market Size by Region (2018-2023)
8.4 Asia-Pacific Neuroscience Antibodies and Assays Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neuroscience Antibodies and Assays Market Size (2018-2033)
9.2 Latin America Neuroscience Antibodies and Assays Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Neuroscience Antibodies and Assays Market Size by Country (2018-2023)
9.4 Latin America Neuroscience Antibodies and Assays Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neuroscience Antibodies and Assays Market Size (2018-2033)
10.2 Middle East & Africa Neuroscience Antibodies and Assays Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Neuroscience Antibodies and Assays Market Size by Country (2018-2023)
10.4 Middle East & Africa Neuroscience Antibodies and Assays Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Detail
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher Neuroscience Antibodies and Assays Introduction
11.1.4 Thermo Fisher Revenue in Neuroscience Antibodies and Assays Business (2018-2023)
11.1.5 Thermo Fisher Recent Development
11.2 Abcam
11.2.1 Abcam Company Detail
11.2.2 Abcam Business Overview
11.2.3 Abcam Neuroscience Antibodies and Assays Introduction
11.2.4 Abcam Revenue in Neuroscience Antibodies and Assays Business (2018-2023)
11.2.5 Abcam Recent Development
11.3 Bio-Rad
11.3.1 Bio-Rad Company Detail
11.3.2 Bio-Rad Business Overview
11.3.3 Bio-Rad Neuroscience Antibodies and Assays Introduction
11.3.4 Bio-Rad Revenue in Neuroscience Antibodies and Assays Business (2018-2023)
11.3.5 Bio-Rad Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Neuroscience Antibodies and Assays Introduction
11.4.4 Merck Revenue in Neuroscience Antibodies and Assays Business (2018-2023)
11.4.5 Merck Recent Development
11.5 Cell Signaling Technology
11.5.1 Cell Signaling Technology Company Detail
11.5.2 Cell Signaling Technology Business Overview
11.5.3 Cell Signaling Technology Neuroscience Antibodies and Assays Introduction
11.5.4 Cell Signaling Technology Revenue in Neuroscience Antibodies and Assays Business (2018-2023)
11.5.5 Cell Signaling Technology Recent Development
11.6 Genscript
11.6.1 Genscript Company Detail
11.6.2 Genscript Business Overview
11.6.3 Genscript Neuroscience Antibodies and Assays Introduction
11.6.4 Genscript Revenue in Neuroscience Antibodies and Assays Business (2018-2023)
11.6.5 Genscript Recent Development
11.7 Rockland Immunochemicals
11.7.1 Rockland Immunochemicals Company Detail
11.7.2 Rockland Immunochemicals Business Overview
11.7.3 Rockland Immunochemicals Neuroscience Antibodies and Assays Introduction
11.7.4 Rockland Immunochemicals Revenue in Neuroscience Antibodies and Assays Business (2018-2023)
11.7.5 Rockland Immunochemicals Recent Development
11.8 BioLegend
11.8.1 BioLegend Company Detail
11.8.2 BioLegend Business Overview
11.8.3 BioLegend Neuroscience Antibodies and Assays Introduction
11.8.4 BioLegend Revenue in Neuroscience Antibodies and Assays Business (2018-2023)
11.8.5 BioLegend Recent Development
11.9 Santa Cruz Biotechnology
11.9.1 Santa Cruz Biotechnology Company Detail
11.9.2 Santa Cruz Biotechnology Business Overview
11.9.3 Santa Cruz Biotechnology Neuroscience Antibodies and Assays Introduction
11.9.4 Santa Cruz Biotechnology Revenue in Neuroscience Antibodies and Assays Business (2018-2023)
11.9.5 Santa Cruz Biotechnology Recent Development
11.10 Roche
11.10.1 Roche Company Detail
11.10.2 Roche Business Overview
11.10.3 Roche Neuroscience Antibodies and Assays Introduction
11.10.4 Roche Revenue in Neuroscience Antibodies and Assays Business (2018-2023)
11.10.5 Roche Recent Development
11.11 Siemens
11.11.1 Siemens Company Detail
11.11.2 Siemens Business Overview
11.11.3 Siemens Neuroscience Antibodies and Assays Introduction
11.11.4 Siemens Revenue in Neuroscience Antibodies and Assays Business (2018-2023)
11.11.5 Siemens Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Neuroscience Antibodies and Assays Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Consumables
Table 3. Key Players of Instruments
Table 4. Global Neuroscience Antibodies and Assays Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Neuroscience Antibodies and Assays Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Neuroscience Antibodies and Assays Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Neuroscience Antibodies and Assays Market Share by Region (2018-2023)
Table 8. Global Neuroscience Antibodies and Assays Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Neuroscience Antibodies and Assays Market Share by Region (2024-2033)
Table 10. Neuroscience Antibodies and Assays Market Trends
Table 11. Neuroscience Antibodies and Assays Market Drivers
Table 12. Neuroscience Antibodies and Assays Market Challenges
Table 13. Neuroscience Antibodies and Assays Market Restraints
Table 14. Global Neuroscience Antibodies and Assays Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Neuroscience Antibodies and Assays Market Share by Players (2018-2023)
Table 16. Global Top Neuroscience Antibodies and Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroscience Antibodies and Assays as of 2022)
Table 17. Ranking of Global Top Neuroscience Antibodies and Assays Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Neuroscience Antibodies and Assays Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Neuroscience Antibodies and Assays Product Solution and Service
Table 21. Date of Enter into Neuroscience Antibodies and Assays Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Neuroscience Antibodies and Assays Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Neuroscience Antibodies and Assays Revenue Market Share by Type (2018-2023)
Table 25. Global Neuroscience Antibodies and Assays Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Neuroscience Antibodies and Assays Revenue Market Share by Type (2024-2033)
Table 27. Global Neuroscience Antibodies and Assays Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Neuroscience Antibodies and Assays Revenue Market Share by Application (2018-2023)
Table 29. Global Neuroscience Antibodies and Assays Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Neuroscience Antibodies and Assays Revenue Market Share by Application (2024-2033)
Table 31. North America Neuroscience Antibodies and Assays Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Neuroscience Antibodies and Assays Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Neuroscience Antibodies and Assays Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Neuroscience Antibodies and Assays Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Neuroscience Antibodies and Assays Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Neuroscience Antibodies and Assays Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Neuroscience Antibodies and Assays Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Neuroscience Antibodies and Assays Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Neuroscience Antibodies and Assays Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Neuroscience Antibodies and Assays Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Neuroscience Antibodies and Assays Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Neuroscience Antibodies and Assays Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Neuroscience Antibodies and Assays Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Neuroscience Antibodies and Assays Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Neuroscience Antibodies and Assays Market Size by Country (2024-2033) & (US$ Million)
Table 46. Thermo Fisher Company Detail
Table 47. Thermo Fisher Business Overview
Table 48. Thermo Fisher Neuroscience Antibodies and Assays Product
Table 49. Thermo Fisher Revenue in Neuroscience Antibodies and Assays Business (2018-2023) & (US$ Million)
Table 50. Thermo Fisher Recent Development
Table 51. Abcam Company Detail
Table 52. Abcam Business Overview
Table 53. Abcam Neuroscience Antibodies and Assays Product
Table 54. Abcam Revenue in Neuroscience Antibodies and Assays Business (2018-2023) & (US$ Million)
Table 55. Abcam Recent Development
Table 56. Bio-Rad Company Detail
Table 57. Bio-Rad Business Overview
Table 58. Bio-Rad Neuroscience Antibodies and Assays Product
Table 59. Bio-Rad Revenue in Neuroscience Antibodies and Assays Business (2018-2023) & (US$ Million)
Table 60. Bio-Rad Recent Development
Table 61. Merck Company Detail
Table 62. Merck Business Overview
Table 63. Merck Neuroscience Antibodies and Assays Product
Table 64. Merck Revenue in Neuroscience Antibodies and Assays Business (2018-2023) & (US$ Million)
Table 65. Merck Recent Development
Table 66. Cell Signaling Technology Company Detail
Table 67. Cell Signaling Technology Business Overview
Table 68. Cell Signaling Technology Neuroscience Antibodies and Assays Product
Table 69. Cell Signaling Technology Revenue in Neuroscience Antibodies and Assays Business (2018-2023) & (US$ Million)
Table 70. Cell Signaling Technology Recent Development
Table 71. Genscript Company Detail
Table 72. Genscript Business Overview
Table 73. Genscript Neuroscience Antibodies and Assays Product
Table 74. Genscript Revenue in Neuroscience Antibodies and Assays Business (2018-2023) & (US$ Million)
Table 75. Genscript Recent Development
Table 76. Rockland Immunochemicals Company Detail
Table 77. Rockland Immunochemicals Business Overview
Table 78. Rockland Immunochemicals Neuroscience Antibodies and Assays Product
Table 79. Rockland Immunochemicals Revenue in Neuroscience Antibodies and Assays Business (2018-2023) & (US$ Million)
Table 80. Rockland Immunochemicals Recent Development
Table 81. BioLegend Company Detail
Table 82. BioLegend Business Overview
Table 83. BioLegend Neuroscience Antibodies and Assays Product
Table 84. BioLegend Revenue in Neuroscience Antibodies and Assays Business (2018-2023) & (US$ Million)
Table 85. BioLegend Recent Development
Table 86. Santa Cruz Biotechnology Company Detail
Table 87. Santa Cruz Biotechnology Business Overview
Table 88. Santa Cruz Biotechnology Neuroscience Antibodies and Assays Product
Table 89. Santa Cruz Biotechnology Revenue in Neuroscience Antibodies and Assays Business (2018-2023) & (US$ Million)
Table 90. Santa Cruz Biotechnology Recent Development
Table 91. Roche Company Detail
Table 92. Roche Business Overview
Table 93. Roche Neuroscience Antibodies and Assays Product
Table 94. Roche Revenue in Neuroscience Antibodies and Assays Business (2018-2023) & (US$ Million)
Table 95. Roche Recent Development
Table 96. Siemens Company Detail
Table 97. Siemens Business Overview
Table 98. Siemens Neuroscience Antibodies and Assays Product
Table 99. Siemens Revenue in Neuroscience Antibodies and Assays Business (2018-2023) & (US$ Million)
Table 100. Siemens Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neuroscience Antibodies and Assays Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Neuroscience Antibodies and Assays Market Share by Type: 2022 VS 2033
Figure 3. Consumables Features
Figure 4. Instruments Features
Figure 5. Global Neuroscience Antibodies and Assays Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Neuroscience Antibodies and Assays Market Share by Application: 2022 VS 2033
Figure 7. Pharmaceutical & Biotechnology Companies Case Studies
Figure 8. Academic & Research Institutes Case Studies
Figure 9. Hospitals & Diagnostic Centers Case Studies
Figure 10. Neuroscience Antibodies and Assays Report Years Considered
Figure 11. Global Neuroscience Antibodies and Assays Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Neuroscience Antibodies and Assays Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Neuroscience Antibodies and Assays Market Share by Region: 2022 VS 2033
Figure 14. Global Neuroscience Antibodies and Assays Market Share by Players in 2022
Figure 15. Global Top Neuroscience Antibodies and Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroscience Antibodies and Assays as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Neuroscience Antibodies and Assays Revenue in 2022
Figure 17. North America Neuroscience Antibodies and Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Neuroscience Antibodies and Assays Market Share by Country (2018-2033)
Figure 19. United States Neuroscience Antibodies and Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Neuroscience Antibodies and Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Neuroscience Antibodies and Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Neuroscience Antibodies and Assays Market Share by Country (2018-2033)
Figure 23. Germany Neuroscience Antibodies and Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Neuroscience Antibodies and Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Neuroscience Antibodies and Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Neuroscience Antibodies and Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Neuroscience Antibodies and Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Neuroscience Antibodies and Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Neuroscience Antibodies and Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Neuroscience Antibodies and Assays Market Share by Region (2018-2033)
Figure 31. China Neuroscience Antibodies and Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Neuroscience Antibodies and Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Neuroscience Antibodies and Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Neuroscience Antibodies and Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Neuroscience Antibodies and Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Neuroscience Antibodies and Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Neuroscience Antibodies and Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Neuroscience Antibodies and Assays Market Share by Country (2018-2033)
Figure 39. Mexico Neuroscience Antibodies and Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Neuroscience Antibodies and Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Neuroscience Antibodies and Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Neuroscience Antibodies and Assays Market Share by Country (2018-2033)
Figure 43. Turkey Neuroscience Antibodies and Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Neuroscience Antibodies and Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Thermo Fisher Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2018-2023)
Figure 46. Abcam Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2018-2023)
Figure 47. Bio-Rad Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2018-2023)
Figure 48. Merck Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2018-2023)
Figure 49. Cell Signaling Technology Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2018-2023)
Figure 50. Genscript Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2018-2023)
Figure 51. Rockland Immunochemicals Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2018-2023)
Figure 52. BioLegend Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2018-2023)
Figure 53. Santa Cruz Biotechnology Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2018-2023)
Figure 54. Roche Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2018-2023)
Figure 55. Siemens Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed